Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their

A C Huggett1, L L Hampton, C P Ford

  • 1Laboratory of Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892.

Cancer Research
|December 1, 1990
PubMed

Insights

Transforming growth factor beta 1 (TGF-beta 1) resistance increases with cancer progression in rat liver cells. Tumorigenic cells lose TGF-beta 1 receptors, impacting growth inhibition and protein synthesis differently.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Transforming growth factor beta 1 (TGF-beta 1) is a key regulator of cell growth and differentiation.
  • v-raf oncogene transformation of rat liver epithelial (RLE) cells leads to a spectrum of neoplastic phenotypes.
  • Understanding TGF-beta 1 signaling in cancer progression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of TGF-beta 1 on DNA synthesis, cell proliferation, and protein synthesis in v-raf-transformed RLE cells.
  • To correlate TGF-beta 1 responsiveness with the degree of cellular transformation and tumorigenicity.
  • To elucidate the mechanisms underlying resistance to TGF-beta 1's biological effects during neoplastic progression.

Main Methods:

  • Culturing of normal RLE cells, control helper virus-infected cells, and v-raf-transformed RLE cells with varying phenotypes.
  • Treatment with TGF-beta 1 to assess effects on DNA synthesis, cell proliferation, and protein secretion (e.g., fibronectin).
  • Quantification of cell-surface TGF-beta 1 receptors and analysis of secreted protein profiles.

Main Results:

  • All v-raf-transformed RLE cells exhibited resistance to TGF-beta 1's growth-inhibitory effects compared to normal RLE cells.
  • Highly tumorigenic cell lines displayed significantly fewer TGF-beta 1 surface receptors and impaired TGF-beta 1-induced protein secretion.
  • Less tumorigenic, more normal-appearing transformed cells retained TGF-beta 1 receptor binding and protein secretion responses.

Conclusions:

  • TGF-beta 1's effects on cell proliferation and specific protein expression are mediated by distinct signaling pathways.
  • v-raf transformation perturbs TGF-beta 1 growth inhibition signaling, while pathways regulating certain protein synthesis may remain intact.
  • Acquisition of resistance to TGF-beta 1's diverse biological actions is a critical event in the in vitro neoplastic transformation of RLE cells.